Many kidney disorders are closely linked with endocrine disease, particularly diabetic kidney disease, chronic kidney disease (CKD)–mineral and bone disorder and endocrine-related hypertension. Diabetic kidney disease is the leading cause of CKD worldwide, reflecting the rising prevalence of obesity and type 2 diabetes. Impaired kidney function disrupts calcium–phosphate and vitamin D metabolism, while also affecting sex hormone balance and fertility. Endocrine disorders can in turn accelerate kidney damage and increase the risk of progression and cardiovascular complications. Management should therefore recognise the close, bidirectional relationship between the kidneys and the endocrine system to address all associated manifestations and outcomes.
Browse video highlights and short articles, providing insights into the latest updates from major conferences and peer-reviewed articles from the journal portfolio. This is complemented by a range of educational activities from our expert faculty, with patient outcomes at the forefront.
Welcome to the summer 2026 issue of touchREVIEWS in Endocrinology. In this issue, we bring together articles that reflect the evolving complexity of endocrine and metabolic disease, while highlighting the growing importance of patient-centred care, translational science and interdisciplinary management. We ...
Urinary lithogenesis processes are activated in patients with obesity, metabolic syndrome (MetS), and type 2 diabetes (T2D). This is a relatively unfamiliar topic among endocrinologists. Beyond the epidemiological evidence accumulated over the recent years, the purpose of this paper is ...
The significance of osteoporosis and fragility fractures in individuals with chronic kidney disease (CKD) is becoming increasingly recognized as a major contributor to disability, hospital admissions and mortality. In CKD, bone fragility is worsened by the complex interactions of metabolic ...
Drawing on the experience of expert faculty and emerging leaders who have already navigated many of the early hurdles when embarking on a career in endocrinology, we asked for one piece of career advice to share with those just starting out. Their reflections highlight the importance of curiosity, compassion, adaptability and purpose in building a fulfilling and sustainable career.
There is no doubt that artificial intelligence was one of the fastest-moving technologies of 2025. Advances in predictive analytics, pattern recognition across large datasets, and the integration of genomic, phenotypic and real-world data are already beginning to reshape how clinicians diagnose disease, stratify risk and personalise care. We asked some of the experts that have collaborated with touchENDOCRINOLOGY what excites them most about AI and how they see it influencing clinical practice.
Dr Sourabh Sharma, a nephrologist and transplant physician at Safdarjung Hospital and Vardhaman Mahaveer Medical College in New Delhi, shares his thoughts on this year’s key advances, the challenges that remain, and the growing impact of AI on nephrology.
In this episode, Nicky speaks with Prof. Georgina Ellison-Hughes from King’s College London about the groundbreaking field of senolytics and their potential to advance the treatment of age-related diseases. From understanding the science behind cellular senescence to how senolytic drugs work and what early clinical trials reveal, this episode explores an exciting frontier in longevity medicine.
As touchENDOCRINOLOGY approaches 22 years of providing education for busy endocrinologists, we are looking to the future—and it certainly looks bright! This year, we are celebrating our inaugural touchENDOCRINOLOGY Future Leaders to recognize the outstanding talent that has entered our ...
In this episode of Visionary Voices, we welcome Associate Professor Grace Vincent from CQUniversity’s Appleton Institute. A leading expert on sleep and shift work, Grace explores how disrupted sleep affects physician health in both the short and long term, as well as its impact on safety and performance. We also discuss what this means for patient outcomes and share practical strategies to manage sleep loss.
Fabry disease experts discuss timely diagnosis and individualized care using genetic and clinical insights.
In this Future Leader Q&A, Dr Ignacio Portales-Castillo reflects on his path from rural primary care in Mexico to physician-scientist at Washington University School of Medicine in St. Louis. He shares how formative patient encounters and exceptional mentors shaped his passion for bone and mineral disorders in chronic kidney disease, how he strives to balance an intense research and clinical workload with family life, and why he believes the future of nephrology–endocrinology lies in both innovative therapies and sustainable, patient-centred care.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions.
Watch three experts discuss the clinical management of rapidly progressing autosomal dominant polycystic kidney disease (ADPKD).
Finerenone (a selective nonsteroidal mineralocorticoid receptor antagonist) and the SGLT2 inhibitor empagliflozin may reduce both kidney and cardiovascular risks in people with chronic kidney disease and type 2 diabetes. It is unknown whether dual therapy with finerenone and empagliflozin is superior ...
Keep track of your clinical interests and newsletter subscriptions.
Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.
Or use a Social Account.
Already registered? Login below.